16:20 EDT Inspire Medical (INSP) down 22% after reporting Q2 earnings, lowering FY25 guidance
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical reports Q2 adjusted EPS 45c, consensus 20c
- Inspire Medical lowers FY25 diluted EPS guidance to 40c-50c from $2.20-$2.30
- INSP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Apnimed says sleep apnea drug meets primary endpoint in Phase 3 trial
- Inspire Medical price target lowered to $197 from $216 at KeyBanc